CIBC Asset Management Inc lowered its stake in shares of Clorox Company (The) (NYSE:CLX) by 0.1% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 17,980 shares of the company’s stock after selling 15 shares during the period. CIBC Asset Management Inc’s holdings in Clorox Company (The) were worth $2,396,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Vanguard Group Inc. boosted its stake in shares of Clorox Company (The) by 4.8% in the first quarter. Vanguard Group Inc. now owns 14,164,716 shares of the company’s stock valued at $1,909,829,000 after buying an additional 649,766 shares in the last quarter. BlackRock Inc. boosted its stake in shares of Clorox Company (The) by 1,402.2% in the first quarter. BlackRock Inc. now owns 10,390,206 shares of the company’s stock valued at $1,400,912,000 after buying an additional 9,698,542 shares in the last quarter. State Street Corp boosted its stake in shares of Clorox Company (The) by 2.2% in the first quarter. State Street Corp now owns 7,648,999 shares of the company’s stock valued at $1,031,304,000 after buying an additional 167,689 shares in the last quarter. Parnassus Investments CA acquired a new stake in shares of Clorox Company (The) during the first quarter valued at about $434,255,000. Finally, Valueinvest Asset Management S.A. boosted its stake in shares of Clorox Company (The) by 6.9% in the first quarter. Valueinvest Asset Management S.A. now owns 1,580,400 shares of the company’s stock valued at $213,085,000 after buying an additional 102,300 shares in the last quarter. Hedge funds and other institutional investors own 70.29% of the company’s stock.

Clorox Company (CLX) opened at 134.21 on Thursday. The stock has a market capitalization of $17.29 billion, a price-to-earnings ratio of 26.51 and a beta of 0.40. The stock’s 50 day moving average is $133.88 and its 200-day moving average is $133.46. Clorox Company has a 12 month low of $111.24 and a 12 month high of $141.76.

Clorox Company (The) (NYSE:CLX) last announced its earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, topping the consensus estimate of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The firm had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.65 billion. During the same period in the prior year, the firm earned $1.30 EPS. The firm’s revenue for the quarter was up 2.9% on a year-over-year basis. On average, equities research analysts expect that Clorox Company will post $5.68 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This article was first reported by Daily Political and is the property of of Daily Political. If you are viewing this article on another site, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The correct version of this article can be viewed at https://www.dailypolitical.com/2017/08/10/cibc-asset-management-inc-sells-15-shares-of-clorox-company-the-nyseclx.html.

Several analysts have recently issued reports on CLX shares. BidaskClub cut shares of Clorox Company (The) from a “hold” rating to a “sell” rating in a research report on Wednesday, July 5th. Zacks Investment Research upgraded shares of Clorox Company (The) from a “hold” rating to a “buy” rating and set a $149.00 target price on the stock in a research report on Tuesday, July 4th. Deutsche Bank AG restated a “hold” rating and set a $137.00 target price (up from $126.00) on shares of Clorox Company (The) in a research report on Saturday, July 22nd. Vetr upgraded shares of Clorox Company (The) from a “hold” rating to a “buy” rating and set a $139.67 target price on the stock in a research report on Monday, April 24th. Finally, Jefferies Group LLC set a $138.00 target price on shares of Clorox Company (The) and gave the company a “hold” rating in a research report on Wednesday, May 3rd. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $129.05.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.